Michael B. Jebsen
2019
In 2019, Michael B. Jebsen earned a total compensation of $399.5K as President and Chief Financial Officer at Tenax Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $59,753 |
|---|---|
| Salary | $339,788 |
| Total | $399,541 |
Jebsen received $339.8K in salary, accounting for 85% of the total pay in 2019.
Jebsen also received $59.8K in non-equity incentive plan.
Rankings
In 2019, Michael B. Jebsen's compensation ranked 12,354th out of 13,971 executives tracked by ExecPay. In other words, Jebsen earned more than 11.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,354 out of 13,971 | 12th |
Division Manufacturing | 4,995 out of 5,695 | 12th |
Major group Chemicals And Allied Products | 1,965 out of 2,194 | 10th |
Industry group Drugs | 1,690 out of 1,880 | 10th |
Industry Pharmaceutical Preparations | 1,251 out of 1,392 | 10th |
Source: SEC filing on April 29, 2020.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2019.
2019
Anthony DiTonno
Tenax Therapeutics